MarketWatch headline: Moderna says Japan regulator has approved partial change to NDA for its omicron-targeting COVID booster
Published: Sept. 12, 2022 at 7:14 a.m. ET
By Ciara Linnane
$MRNA daily chart poised for a breakout
$MRNA weekly chart
$MRNA monthly chart